Soft Tissue Sarcoma Treatment Market: Industry Trends, Key Players, and Market Opportunities
Valued at USD 1,455.12 million in 2024, the soft tissue sarcoma treatment market is projected to reach USD 1,603.69 million in 2025 and USD 3,910.15 million by 2034, growing at a CAGR of 10.4% during the forecast period 2025–2034. North America was the largest regional market in 2024. Major players include Amgen Inc., AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly and...
0 Reacties 0 aandelen 285 Views 0 voorbeeld